| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |